Clinical trial
Semaglutide for Dialysis-Treated Patients - a Glucose Time in Range Study- DIALYSIS-TIR Study
NCT06042153 is registered in ClinicalTrials.gov with University of Texas Southwestern Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Semaglutide for Dialysis-Treated Patients - a Glucose Time in Range Study- DIALYSIS-TIR Study
- Lead sponsor
- University of Texas Southwestern Medical Center
- Phase
- Phase 4
- Overall status
- Active, not recruiting
- Start date
- December 5, 2023
- Completion date
- September 30, 2028
- Enrollment
- 43 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
end stage renal disease on dialysis, type 2 diabetes